NASDAQ: SLS
Sellas Life Sciences Group Inc Stock Ownership - Who owns Sellas Life Sciences Group?

Insider buying vs selling

Have Sellas Life Sciences Group Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nostrand Robert L. VanDirector2025-06-1210,000$1.48
$14.80kBuy
Jane WasmanDirector2025-05-3020,000$1.69
$33.80kBuy
Katherine Bach KalinDirector2025-05-2220,000$1.80
$36.00kBuy
John Thomas BurnsCFO2024-12-047,165$1.13
$8.10kSell
Dragan CicicSVP Chief Development Officer2024-12-048,256$1.13
$9.33kSell
Angelos M. StergiouPresident and CEO2024-12-0428,289$1.13
$31.97kSell

1 of 1

SLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLS insiders and whales buy or sell their stock.

SLS Shareholders

What type of owners hold Sellas Life Sciences Group Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc6.32%6,654,799$12.31MInstitution
Blackrock Inc4.36%4,590,273$8.49MInstitution
Hudson Bay Capital Management LP4.18%4,400,000$8.14MInsider
Marshall Wace LLP2.58%2,715,489$5.02MInstitution
Geode Capital Management LLC2.09%2,200,428$4.07MInstitution
Susquehanna International Group LLP1.41%1,489,672$2.76MInstitution
Robert Eugene Kennedy1.07%1,130,300$2.09MInsider
Millennium Management LLC1.07%1,127,225$2.09MInstitution
State Street Corp1.06%1,112,705$2.06MInstitution
Morgan Stanley1.03%1,084,478$2.01MInstitution

1 of 3

SLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLS25.42%8.22%Net Buying
TIL5.76%94.24%Net BuyingNet Buying
IPHA0.12%0.00%
BDTX65.69%34.31%Net SellingNet Buying
CRBU43.80%8.85%Net Buying

Sellas Life Sciences Group Stock Ownership FAQ

Who owns Sellas Life Sciences Group?

Sellas Life Sciences Group (NASDAQ: SLS) is owned by 25.42% institutional shareholders, 8.22% Sellas Life Sciences Group insiders, and 66.35% retail investors. Hudson Bay Capital Management LP is the largest individual Sellas Life Sciences Group shareholder, owning 4.40M shares representing 4.18% of the company. Hudson Bay Capital Management LP's Sellas Life Sciences Group shares are currently valued at $7.39M.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.